Shuang Qi

1.2k total citations
56 papers, 751 citations indexed

About

Shuang Qi is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Shuang Qi has authored 56 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Surgery. Recurrent topics in Shuang Qi's work include Gastrointestinal Tumor Research and Treatment (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Histone Deacetylase Inhibitors Research (3 papers). Shuang Qi is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Histone Deacetylase Inhibitors Research (3 papers). Shuang Qi collaborates with scholars based in China, United States and Spain. Shuang Qi's co-authors include Feihu Zhou, Zhi Mao, Xiaoming Li, Chao Liu, Li Wang, Minglu Xiao, Qingsong Liu, Aoli Wang, Jing Liu and Qianxiong Zhou and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Chemical Communications.

In The Last Decade

Shuang Qi

56 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuang Qi China 15 182 163 144 120 113 56 751
Yueming Li China 19 164 0.9× 159 1.0× 413 2.9× 215 1.8× 48 0.4× 52 1.2k
Yichen Li China 18 184 1.0× 463 2.8× 220 1.5× 113 0.9× 86 0.8× 63 1.0k
Saeed K Alzghari United States 13 102 0.6× 189 1.2× 226 1.6× 58 0.5× 66 0.6× 22 930
Sanjay Gambhir India 20 107 0.6× 107 0.7× 151 1.0× 107 0.9× 29 0.3× 131 1.2k
Joseph Bubalo United States 20 155 0.9× 136 0.8× 243 1.7× 160 1.3× 124 1.1× 64 1.4k
Yanmei Sun China 17 50 0.3× 232 1.4× 187 1.3× 75 0.6× 28 0.2× 49 971
Fengming Luo China 20 110 0.6× 247 1.5× 136 0.9× 142 1.2× 67 0.6× 92 1.3k
Shujie Wang China 21 82 0.5× 303 1.9× 202 1.4× 189 1.6× 30 0.3× 116 1.4k
Chen Shi China 19 157 0.9× 375 2.3× 100 0.7× 52 0.4× 69 0.6× 61 1.1k
Parag Kumar United States 18 238 1.3× 285 1.7× 103 0.7× 160 1.3× 45 0.4× 43 1.2k

Countries citing papers authored by Shuang Qi

Since Specialization
Citations

This map shows the geographic impact of Shuang Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuang Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuang Qi more than expected).

Fields of papers citing papers by Shuang Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuang Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuang Qi. The network helps show where Shuang Qi may publish in the future.

Co-authorship network of co-authors of Shuang Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Shuang Qi. A scholar is included among the top collaborators of Shuang Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuang Qi. Shuang Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Qi, Shuang, Mingchao Shi, Chao Li, et al.. (2024). Associations between NIHSS sub-item scores and prognosis and intracranial hemorrhage after endovascular therapy for acute anterior circulation ischemic stroke. Frontiers in Neurology. 14. 1320055–1320055. 3 indexed citations
3.
4.
Wang, Junjie, Ziping Qi, Yun Wu, et al.. (2023). Discovery of IHMT-MST1-39 as a novel MST1 kinase inhibitor and AMPK activator for the treatment of diabetes mellitus. Signal Transduction and Targeted Therapy. 8(1). 143–143. 12 indexed citations
5.
Wang, Aoli, Juan Liu, Xixiang Li, et al.. (2023). Discovery of a highly potent pan-RAF inhibitor IHMT-RAF-128 for cancer treatment. European Journal of Pharmacology. 952. 175752–175752. 2 indexed citations
6.
Mei, Husheng, Jing Yang, Bin Zhou, et al.. (2023). Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignancies. Signal Transduction and Targeted Therapy. 8(1). 18–18. 19 indexed citations
7.
Liang, Xiaofei, Fengming Zou, Ziping Qi, et al.. (2023). Discovery of Pyrazolo[1,5-a]pyrimidine derivative as a potent and selective PI3Kγ/δ dual inhibitor. European Journal of Medicinal Chemistry. 260. 115768–115768. 5 indexed citations
8.
Wu, Yun, Ziping Qi, Beilei Wang, et al.. (2022). Discovery of IHMT-MST1-58 as a Novel, Potent, and Selective MST1 Inhibitor for the Treatment of Type 1/2 Diabetes. Journal of Medicinal Chemistry. 65(17). 11818–11839. 9 indexed citations
9.
Liu, Juan, Jingjing Gao, Aoli Wang, et al.. (2022). Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib‐induced KIT mutations in gastrointestinal stromal tumours. Molecular Oncology. 16(8). 1761–1774. 7 indexed citations
10.
Zhou, Bin, Xiaofei Liang, Husheng Mei, et al.. (2021). Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell Lymphomas. Journal of Medicinal Chemistry. 64(20). 15170–15188. 18 indexed citations
11.
Li, Xiaoming, Chao Liu, Zhi Mao, et al.. (2020). Short‐course versus long‐course antibiotic treatment in patients with uncomplicated gram‐negative bacteremia: A systematic review and meta‐analysis. Journal of Clinical Pharmacy and Therapeutics. 46(1). 173–180. 11 indexed citations
12.
13.
14.
15.
Li, Xiaoming, Chao Liu, Zhi Mao, et al.. (2020). Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Critical Care. 24(1). 647–647. 238 indexed citations
16.
17.
Li, Xiaoming, Chao Liu, Zhi Mao, et al.. (2020). Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock: A systematic review and meta-analysis. Journal of Critical Care. 63. 187–195. 27 indexed citations
18.
19.
20.
Qi, Shuang. (2008). Clinical Analysis on the Relationship Between Human Papillomavirus Infection and the Age of Patients with Cervical Carcinoma. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yueming Li Breakdown of academic impact, for papers by Yichen Li Breakdown of academic impact, for papers by Saeed K Alzghari Breakdown of academic impact, for papers by Sanjay Gambhir Breakdown of academic impact, for papers by Joseph Bubalo Breakdown of academic impact, for papers by Yanmei Sun Breakdown of academic impact, for papers by Fengming Luo Breakdown of academic impact, for papers by Shujie Wang Breakdown of academic impact, for papers by Chen Shi Breakdown of academic impact, for papers by Parag Kumar
Rankless by CCL
2026